Alzheimer’s disease is linked to the build-up of an abnormal protein in the brain called amyloid beta. Early on, this process doesn’t cause any obvious symptoms. But later, cognitive problems such as memory loss may emerge. The question is, could targeting amyloid beta prevent this? To answer this question and more, we need your help. …
COULD YOU HELP US IN THE FIGHT AGAINST ALZHEIMER’S DISEASE? Read More »
Multiple Sclerosis is a long-term illness where the body’s immune system attacks and damages the protective covering (called myelin) around the nerves in the central nervous system. People with relapsing MS (relapsing-remitting MS or secondary progressive MS with relapses) will have repeated attacks, or “relapses.” The purpose of this study is to find out if patients …
RELAPSING-REMITTING MS OR SECONDARY PROGRESSIVE MS WITH RELAPSES? Read More »
As part of a paid research study, we are conducting cognitive and other testing on volunteers who have been diagnosed with Multiple Sclerosis. Tests will be conducted every 6 months and participants will be compensated $500.00 for the screening visit, plus $500.00 for each completed six-month follow-up visit. The purpose of this research study is …
WE’RE SEEKING QUALIFIED VOLUNTEERS FOR MS CLINICAL RESEARCH Read More »
This research study is evaluating an investigational drug combination, CST-2032 combined with CST-107 (nadolol), as a possible treatment for cognitive impairment due to Alzheimer’s disease (AD) or Parkinson’s disease (PD) with rapid eye movement (REM) sleep behavior disorder. Alzheimer’s Disease is a type of brain disease, just as coronary artery disease is a type of …
COGNITIVE IMPAIRMENT DUE TO ALZHEIMER’S OR PARKINSON’S DISEASE? Read More »
If you or a loved one has Parkinson’s disease, your biological sample donation could be the missing link to finding these better treatments and cure. Since 1992, Bradenton Research Center has completed over 150 clinical research studies. The diseases we’ve studied include Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis, Influenza, Migraines, Neuropathic Pain, Gout, Hypertension, Stroke, Type …
DO YOU KNOW SOMEONE WHO HAS PARKINSON’S DISEASE? Read More »
If you’re at risk for Alzheimer’s Disease, you may be eligible for a clinical research study. Your brain may show signs of Alzheimer’s disease, before you notice any changes in your memory or ability to think clearly. Those at risk may prequalify for this clinical research study on Alzheimer’s disease. In order to meet study eligibility …
Are you or someone you care for with Alzheimer’s Dementia exhibiting excessive motor activity, verbal and/or physical aggression? If so, you/they may qualify for The ASPECT Study. The purpose of this study is to evaluate the safety and effectiveness of an investigational drug for agitation associated with Alzheimer’s Dementia. Alzheimer’s Disease is a progressive disease …
HAVE A DIAGNOSIS PROBABLE OF ALZHEIMER’S DEMENTIA? Read More »
Multiple Sclerosis (MS) is a chronic disease affecting the brain and spinal cord. People with MS can experience a variety of symptoms, including problems with vision, bladder control, arm or leg movement, sensation, or balance. Relapsing MS is characterized by attacks, also called relapses, meaning new or worsening of symptoms lasting for at least 24 …
Learn more about getting involved in clinical trials. Receive compensation and free medical care, while helping with the advancements of medical research. Since 1992, Bradenton Research Center has completed over 150 clinical research studies. The diseases we’ve studied include Parkinson’s Disease, Alzheimer’s Disease, Influenza, Migraines, Neuropathic Pain, Gout, Hypertension, Stroke, Type 2 Diabetes, Diabetic Neuropathy, Epilepsy, COVID-19, …
Bradenton Research Center is a dedicated research facility led by Medical Director Eric Folkens, M.D. Located in Bradenton, we do serve the greater southwest Florida area and are fighting the battle with so many who suffer from varying medical conditions. With a team of knowledgeable and experienced staff, our goal is to find better treatments than …
Copyright © 2023 Bradenton Research Center | Website Designed by Rohring Results
